Stock Price
1.12
Daily Change
-0.13 -10.14%
Monthly
-19.42%
Yearly
-58.52%
Q3 Forecast
1.11

X T L Biopharmaceuticals reported $289K in Sales Revenues for its fiscal quarter ending in December of 2024.


Sales Change Date
Alaunos Therapeutics USD 0 4K Sep/2024
Bioline Rx USD 304K 4.64M Jun/2025
Teva Pharmaceutical Industries USD 14.06B 0 Jun/2025
X T L Biopharmaceuticals USD 289K 127K Dec/2024